الى الركن العربى
Username:   
Password:   

Register

  Search

     
All Words Any Words
 
   
EHS From the Editor
   

What happened in Vancouver Canada?
Global Cardiovascular Risk Reduction

During the period from 26 to 30 September, 2010, the 23rd scientific meeting of the International Society of Hypertension (ISH) took place.
This 2010 meeting consisted of four days packed fell of outstanding science & reduction focusing on Cardiovascular Risk& Cardiovascular Diseases, The meeting dealt with Hypertension at all levels of research including pathophysiology, clinical medicine management and prevention, investigation, and therapy.

We can't lose right of the fact that Hypertension is a key factor leading to arterial disease with its consequences on the brain, heart, kidney, and other organs. The fight is not yet won. ISH 2010 was inclusive of diabetes, mellitus, obesity, dyslipidemia and other factors that contribute to the development of the leading cause of death & disability in many countries especially the developing area like our Egypt.

Two important issues were found upon in the satellite symposia session. First a review of the preponderance of evidence supporting the lifestyle treatment of Hypertension as an essential step to maximize the prevention of atherosclerosis, stroke, congestive heart failure, chronic, renal disease , and premature death.

Second issue was about the progressive awareness regarding the limitations of conventional spot blood pressure measurements obtained either in the office or in the clinic and its impact on assessing the severity of Hypertension & prediction of risk.

The recommendation after the state of Arterial Blood Pressure Assessment in practice session was to encourage out of office blood pressure measurements largely based on the use of automated devices, both for home and ambulatory monitoring over 24 hours.

Exercise, diet, restriction of salt intake, loosing weight was discussed largely & their role in lowering cardiovascular risk was emphasized, by various clinical trials, in different communities.

 

Dr. Wafaa El-Aroussy, MD

Prof. of Cardiology - Cairo University